Biomerica (BMRA) Earnings Analysis

Biomerica (BMRA) next reports earnings on 2026-08-27, consensus EPS -1.2 USD. Last quarter (2026-04-13) it beat with EPS -0.44 USD vs -1.2 USD est (+63.3%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E -1.50.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does BMRA next report earnings?

Next earnings date2026-08-27
Consensus EPS estimate-1.2 USD
Revenue estimate0.00B

BMRA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-13-0.44 USD-1.2 USD+63.3%Beat
2026-01-14-0.45 USDn/an/an/a
2025-10-140.00076 USDn/an/an/a
2025-04-14-0.48 USDn/an/an/a
2025-01-14-0.06 USDn/an/an/a
2024-10-15-0.08 USDn/an/an/a

Beat rate: 1/1 (100%) over reported quarters with consensus data.

BMRA valuation and analyst view

Trailing P/E-1.50
Trailing EPS-1.38657 USD
Price / book1.42
Dividend yield0.00%
Market cap0.01B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Biomerica (BMRA)'s next earnings date?

Biomerica is next scheduled to report on 2026-08-27, with a consensus EPS estimate of -1.2 USD and revenue estimate of 0.00B.

Did BMRA beat earnings last quarter?

In its 2026-04-13 report, BMRA posted EPS of -0.44 USD versus a -1.2 USD estimate — a beat of 63.3%.

What is BMRA's earnings track record?

Over the last 1 reported quarters with consensus data, BMRA beat estimates 1 times (100%).

What is BMRA's current P/E ratio and EPS?

BMRA trades at a trailing P/E of -1.50 on trailing EPS of -1.3865690819676924 USD.

What do analysts rate BMRA?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).